Terms: = Liver cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Clinical Outcome
16 results:
1. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer.
Ortiz-Barahona V; Soler M; Davalos V; García-Prieto CA; Janin M; Setien F; Fernández-Rebollo I; Bech-Serra JJ; De La Torre C; Guil S; Villanueva A; Zhang PH; Yang L; Guarnacci M; Schumann U; Preiss T; Balaseviciute U; Montal R; Llovet JM; Esteller M
Mol Cancer; 2023 May; 22(1):83. PubMed ID: 37173708
[TBL] [Abstract] [Full Text] [Related]
3. Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis.
Garbarino O; Lambroia L; Basso G; Marrella V; Franceschini B; Soldani C; Pasqualini F; Giuliano D; Costa G; Peano C; Barbarossa D; Annarita D; Salvati A; Terracciano L; Torzilli G; Donadon M; Faggioli F
Aging Cell; 2023 Jul; 22(7):e13853. PubMed ID: 37157887
[TBL] [Abstract] [Full Text] [Related]
4. Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation.
Mucha B; Qie S; Bajpai S; Tarallo V; Diehl JN; Tedeschi F; Zhou G; Gao Z; Flashner S; Klein-Szanto AJ; Hibshoosh H; Masataka S; Chajewski OS; Majsterek I; Pytel D; Hatzoglou M; Der CJ; Nakagawa H; Bass AJ; Wong KK; Fuchs SY; Rustgi AK; Jankowsky E; Diehl JA
Nat Commun; 2022 Nov; 13(1):6614. PubMed ID: 36329064
[TBL] [Abstract] [Full Text] [Related]
5. Low
Yim SY; Kang SH; Shin JH; Jeong YS; Sohn BH; Um SH; Lee JS
Cells; 2020 Sep; 9(9):. PubMed ID: 32878261
[TBL] [Abstract] [Full Text] [Related]
6. High expression of Krüppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer.
Takagi Y; Sakai N; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Suzuki D; Kagawa S; Mishima T; Nakadai E; Miyauchi H; Matsubara H; Ohtsuka M
Cancer Sci; 2020 Jun; 111(6):2078-2092. PubMed ID: 32279400
[TBL] [Abstract] [Full Text] [Related]
7. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
[TBL] [Abstract] [Full Text] [Related]
8. Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis.
Gu L; Zhu Y; Lin X; Li Y; Cui K; Prochownik EV; Li Y
Cancer Res; 2018 Oct; 78(20):5808-5819. PubMed ID: 30143522
[TBL] [Abstract] [Full Text] [Related]
9. A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.
Singh V; Manalang M; Singh M; Apte U
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):654-657. PubMed ID: 28187036
[TBL] [Abstract] [Full Text] [Related]
10. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract] [Full Text] [Related]
11. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T
Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201
[TBL] [Abstract] [Full Text] [Related]
12. The rs6983267 SNP is associated with myc transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract] [Full Text] [Related]
13. Molecular signatures and prognosis of hepatocellular carcinoma.
Hoshida Y
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M; Biasi F; Feo F; Pascale RM
Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
[TBL] [Abstract] [Full Text] [Related]
15. Bilateral adrenal neuroblastoma.
Zaizen Y; Suita S; Yamanaka K; Nagoshi M; Tsuda T
Eur J Pediatr Surg; 1997 Oct; 7(5):304-7. PubMed ID: 9402493
[TBL] [Abstract] [Full Text] [Related]
16. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract] [Full Text] [Related]